WOLVERINE TRADING, LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 162 filers reported holding CARA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$37,800
-58.8%
22,500
-30.1%
0.00%
Q2 2023$91,770
-14.2%
32,200
+190.1%
0.00%
Q2 2022$107,000
-76.7%
11,100
-70.2%
0.00%
Q4 2021$460,000
-55.3%
37,300
-47.7%
0.00%
-100.0%
Q2 2021$1,030,000
+36.1%
71,365
+93.9%
0.00%
+100.0%
Q1 2021$757,000
-1.4%
36,800
-26.3%
0.00%
Q4 2020$768,000
+14.8%
49,965
-7.7%
0.00%
-100.0%
Q3 2020$669,000
-60.4%
54,138
-46.3%
0.00%
-50.0%
Q2 2020$1,690,000
+27.9%
100,726
+1.2%
0.00%0.0%
Q1 2020$1,321,000
-22.2%
99,532
-3.9%
0.00%
-20.0%
Q4 2019$1,699,000
-21.8%
103,554
-11.2%
0.01%
-16.7%
Q3 2019$2,173,000
-34.5%
116,638
-24.4%
0.01%
-40.0%
Q2 2019$3,316,000
-21.2%
154,288
-28.0%
0.01%
-16.7%
Q1 2019$4,206,000
+114.8%
214,375
+39.1%
0.01%
+100.0%
Q4 2018$1,958,000
-48.2%
154,157
-2.3%
0.01%
-25.0%
Q3 2018$3,778,000
+271.9%
157,754
+92.1%
0.01%
+300.0%
Q2 2018$1,016,0000.0%82,1060.0%0.00%0.0%
Q1 2018$1,016,00082,1060.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 2,799,058$42,350,00022.29%
Chescapmanager LLC 1,314,603$19,890,0002.42%
Prosight Management, LP 294,041$4,449,0002.06%
DAFNA Capital Management LLC 261,442$3,956,0001.18%
Cypress Capital Management LLC (WY) 81,269$1,230,0001.06%
KINGDON CAPITAL MANAGEMENT, L.L.C. 626,583$9,480,0001.02%
Carmignac Gestion 1,851,443$28,012,0000.29%
FARALLON CAPITAL MANAGEMENT LLC 2,465,000$37,295,0000.22%
Ikarian Capital, LLC 301,700$4,565,0000.20%
DISCIPLINED GROWTH INVESTORS INC /MN 689,899$10,438,0000.20%
View complete list of CARA THERAPEUTICS INC shareholders